J7639 – Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7639
- Long description
- Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- Short description
- Dornase alfa non-comp unit
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
D1GDrugs Administered through DME- Added
- January 1, 2000
- Last change
- January 1, 2009 – No change
Frequently asked questions
What is HCPCS code J7639?
J7639 is a HCPCS Level II code for dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram.
Does Medicare cover J7639?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7631 – Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7632 – Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7633 – Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
- J7634 – Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
- J7635 – Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7636 – Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7637 – Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7638 – Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7640 – Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641 – Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642 – Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643 – Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7644 – Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7645 – Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7647 – Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7648 – Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.